✦ LIBER ✦

PCN1 THIRD-GENERATION AROMATASE INHIBITORS VS TAMOXIFEN IN THE TREATMENT OF EARLY AND ADVANCED BREAST CANCER: A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS

✍ Scribed by R von Maltzahn; SJ Edwards

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Third-generation aromatase inhibitors in

✍ Jean-Marc A. Nabholtz; David M. Reese 📂 Article 📅 2001 🏛 Springer Japan 🌐 English ⚖ 517 KB

Fulvestrant in the treatment of advanced

✍ Antonis Valachis; Davide Mauri; Nikolaos P. Polyzos; Dimitris Mavroudis; Vassili 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Systematic review of early vs deferred h

✍ Gregory Boustead; Steven J. Edwards 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

A comparison of fulvestrant and the thir

✍ David Dodwell; Ignace Vergote 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 317 KB

A Systematic Review and Methodological E

✍ John-Baptiste, Ava A.; Wu, Wei; Rochon, Paula; Anderson, Geoffrey M.; Bell, Chai 📂 Article 📅 2013 🏛 Public Library of Science 🌐 English ⚖ 210 KB

Second- and Third-generation Aromatase I

✍ Elledge, R.M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 94 KB